The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Share News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 250 movers: Redrow falls despite rise in profits

Tue, 09th Feb 2016 14:47

(ShareCast News) - The FTSE 250 continued to slide on Tuesday, with the second tier market down 140.79 points (0.91%) to 15,357.20 by mid-afternoon.Redrow was near the top of the fallers list despite posting a rise in first half pre-tax profit as revenue and completions grew.In the six months to the end of December, pre-tax profit increased 14% to a record £104m, on revenue of £603m, up 8% from the same period in 2015. Earnings per share, meanwhile, were 15% higher at 22.9p and the operating margin was 18.2% versus 17% the previous year. Legal completions were up 18% in the period to 2,178, with Help to Buy continuing to support demand. In addition, the company announced an interim dividend of 4p per share, which was double that of last year, and guidance of 10p for the year, compared to 6p in 2015.Chairman Steve Morgan said: "We are only at the beginning of the spring selling season, however demand for new homes remains robust. We ended the first half with a record order book up 51% on this time last year, and in the first six weeks of the second half have secured 455 private reservations, 10% ahead of last year." However the company did confirm it has seen a slowdown in London despite the rest of the UK performing well.Sophos Group's third quarter results were hit by the strong dollar depleting some of its gains made through a major acquisition in the three months to 31 December 2015.Like-for-like billings were up 17.4% year-on-year, with growth across all major regions and product categories, though notwithstanding stronger quarterly comparatives. Sophos' reported billings grew 10.6% year-on-year, reflecting significant currency headwinds including the devaluation of both sterling and the euro against the US dollar. Reported revenue in the quarter was $121.4m (£84.16m), up 4.7% over 12 months earlier, or 11.9% growth on a constant currency basis. Its reported cash EBITDA was $34.8m, up 5.5% year-on-year or 16.3% at constant currency.Investors also weren't convinced with Allied Minds saying that 2015 was a year of investment rather than cashflow, as it updated the market of its trading in the 12 months to 31 December 2015.The company had net cash and investments - including cash in the form of fixed income securities - of $194.8m (£135.37m) at the end of the year, down from $261.5m at the end of 2014. Revenues fell during the year to $3.2m, from $7.7m, with the board blaming revenue shortfall at RF Biocidics, with following initial regulatory approval now required certification for each individual installation, delaying revenue.During 2015, the firm invested $102.8m into new and existing portfolio companies, including leading fundraisings of $63.6m - with $42.2m coming from third-party investment - to accelerate the development of two of the group's existing companies.Meanwhile Poundland continued to rise on Tuesday, a day after Deutsche Bank upgraded the company from 'hold' to 'buy' - a move it said was controversial.It said the company has had a challenging start to the year, but believed the company can help itself to offset the challenges it faces. It also noted consensus earnings for the year to the end of March have fallen by 40%, due to weak sales and the 99p Stores business."We have little expectation that like for like sales trends will improve in the near-term, so operational deleverage risks remain." However, Deutsche Bank did see two years of "exceptionally strong" earnings growth, and believed positive catalysts from the company's multi-price trials in the UK could alleviate concerns about the business model.FTSE 250 - RisersAcacia Mining (ACA) 237.00p 3.31%QinetiQ Group (QQ.) 218.80p 3.21%Aveva Group (AVV) 1,263.00p 2.10%IG Group Holdings (IGG) 711.00p 1.72%Cineworld Group (CINE) 463.40p 1.40%Daejan Holdings (DJAN) 5,815.00p 1.13%Ultra Electronics Holdings (ULE) 1,794.00p 1.07%Poundland Group (PLND) 148.10p 0.95%Kier Group (KIE) 1,227.00p 0.90%B&M European Value Retail S.A. (DI) (BME) 276.00p 0.88%FTSE 250 - FallersVedanta Resources (VED) 217.80p -10.74%Redrow (RDW) 381.60p -9.57%Sophos Group (SOPH) 187.40p -9.12%Enterprise Inns (ETI) 71.85p -9.05%OneSavings Bank (OSB) 264.70p -7.99%Aldermore Group (ALD) 180.00p -7.07%Shawbrook Group (SHAW) 261.60p -6.77%Allied Minds (ALM) 279.00p -6.47%Virgin Money Holdings (UK) (VM.) 270.30p -6.34%Vectura Group (VEC) 168.00p -5.88%
More News
24 Oct 2016 08:30

Allied Minds raises £5m from Neil Woodford for prostate cancer technology

(ShareCast News) - Star UK fund manager Neil Woodford has bought £5m of new shares in Allied Minds subsidiary Precision Biopsy. Woodford Investment Management, which is already a substantial shareholder in FTSE 250-listed Allied Minds purchased 0.95m preference shares in Precision Biopsy. Having de

Read more
29 Sep 2016 08:12

Allied Minds partners with GE Ventures to commercialise emerging tech

(ShareCast News) - FTSE 250 intellectual property company Allied Minds partnered with General Electric's venture capital subsidiary to commercialise next generation technologies. Allied Minds and GE Ventures agreed to invest in new and existing technologies from each of their innovation pipelines.

Read more
25 Aug 2016 08:05

Allied Minds losses increase but focus remains on future potential

(ShareCast News) - Allied Minds, the university and government technology commercialisation specialist, reported an increased loss, smaller revenue and flat value of its investment assets over the first half of the year. However, the company remains more firmly focused on investing in its various as

Read more
22 Aug 2016 07:07

Allied Minds secures debt funding and raises funds for drug programme

(ShareCast News) - Venture capital-style investor Allied Minds has arranged a one-year debt facility Silicon Valley Bank in the US, while its drug discovery subsidiary has raised funds for its leading project from institutional investors. Secured over certain group assets, the $20m one-year facility

Read more
1 Aug 2016 08:12

Allied Minds investment SciFluor gets nod from FDA

(ShareCast News) - Life science and technology investor Allied Minds announced on Monday that one of its key subsidiaries, SciFluor Life Sciences, has achieved the necessary scientific and regulatory milestones to enter clinical trials. The FTSE 250 company said SciFluor's Investigational New Drug a

Read more
13 Jun 2016 16:35

DIRECTOR DEALINGS: Allied Minds COO Marc Eichenberger Sells Shares

Read more
27 May 2016 15:30

FTSE 250 movers: Phoenix Group firms on AXA Wealth deal

(ShareCast News) - FTSE 250 was marginally firmer in late afternoon trade as UK traders wound down ahead of a long weekend, with few of today's in-the-news mid-cap stocks figuring among that index's top-10 risers. Shares in Phoenix Group Holdings were ahead as it agreed with AXA UK to buy AXA Wealth

Read more
25 May 2016 10:04

Allied Minds announces successful completion of feasibility programme

(ShareCast News) - Allied Minds' partnership with Bristol-Myers Squibb (BMS), Allied-Bristol Life Sciences, has successfully completed the drug candidate feasibility programme ABLS II and has approved up to $15m to fund further development of the lead optimisation programme. ABLS II is seeking to de

Read more
25 May 2016 07:08

Allied Minds Approves USD15 Million Funding For Allied-Bristol

Read more
19 May 2016 15:03

AGM, EGM Calendar - Week Ahead

Read more
13 May 2016 11:42

DIRECTOR DEALINGS: Allied Minds COO Sells 49,242 Shares

Read more
26 Apr 2016 09:30

WINNERS & LOSERS SUMMARY: Cobham Crushed On Weak Profit, Rights Issue

Read more
26 Apr 2016 08:47

Allied Minds secures £55m funding for up to ten new drugs

(ShareCast News) - Science and technology development and commercialisation company Allied Minds announced a fresh $80m (£55m) of investment commitments on Tuesday, received through its newly-formed subsidiary ABLS Capital. The FTSE 250 firm said the funding would allow up to ten potential lead opti

Read more
26 Apr 2016 06:50

Allied Minds Secures USD80 Million Commitments For Drug Development

Read more
25 Apr 2016 14:07

FTSE 250 movers: Ted Baker boosted as strike threat hits Wood Group

(ShareCast News) - The FTSE 250 remained in the black in afternoon trading on Monday, though some stocks were under the pump as crude and copper prices fell. Ted Baker was one of the leading risers, after analysts at Jefferies upgraded the stock to 'buy' from 'hold', though they did cut the price ta

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.